Utah Medical Products Net Total Equity Issued/Repurchased 2010-2024 | UTMD
Utah Medical Products net total equity issued/repurchased from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
| Utah Medical Products Annual Net Total Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $-20 |
| 2023 | $0 |
| 2022 | $-2 |
| 2021 | $1 |
| 2020 | $-7 |
| 2019 | $0 |
| 2018 | $-1 |
| 2017 | $0 |
| 2016 | $-2 |
| 2015 | $0 |
| 2014 | $-1 |
| 2013 | $1 |
| 2012 | $1 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.173B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||